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Purpose: The aim of this study was to compare short-term morbidities and mortalities of elective surgery
after stent insertion and emergency surgery in obstructive colorectal cancer.
Methods: We retrospectively reviewed 77 patients with obstructive colorectal cancer that underwent
elective surgery after stenting (stent group: SG, n ¼ 49) or emergent surgery (emergency group: EG,
n ¼ 28) from January 2000 to July 2010.
Results: The American Society of Anesthesiologists (ASA) score of SG was lower than that of EG
(p ¼ 0.015). The percentages of open and laparoscopic surgery in SG were 73.5% (36/49) and 26.5% (13/
49), respectively, whereas surgery in EG was performed using an open technique (p ¼ 0.003). The rate of
primary anastomosis, without constructing a stoma, was 87.8% in SG and 42.9% in EG (p < 0.001). There
was no difference in a postoperative complication. Anastomotic leakage according to time between stent
placement and surgery in SG were 3 cases for 1e9 days and 0 for more than 10 days (p ¼ 0.037). Three-
year overall survival rates were 68.8% and 51.3% (p ¼ 0.430), respectively.
Conclusion: Preoperative stent insertion in obstructive colorectal cancer seems to be safe and feasible,
and may decrease second stage procedure. Waiting 10 days after stent placement may be a more optimal
time for surgical intervention. Further prospective randomized studies are needed to determine the
proper time bridge to surgery following stent insertion in obstructive colorectal cancer.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
The incidence of colorectal cancer continues to increase in Ko-
rea, and it now stands as the second most common cancer in men
and the third most common in women; accounting for 15.2% and
10.6% of cancer cases, respectively.1 Acute colorectal obstruction is
usually caused by malignancy, and is encountered in 8e25% of
colorectal cancer cases.2,3
Emergency surgery for obstructive colorectal cancer is associ-
ated with increased morbidity and mortality rates, especially in
older patients or in those with a poor general condition.4 The
insertion of a stents in obstructive colorectal cancer allows patients
to recover general condition, facilitates bowel decompression for
elective surgery and one-stage procedures, avoids stoma formation,
and reducesmorbidity.5e8 Patients fear multi-step surgery, and ﬁnd: þ82 32 460 3247.
k).
to this study.
ciates Ltd. Published by Elsevier Lta stoma embarrassing. In fact, only 60% of patients with a repairable
stoma undergo stoma repair.9,10 Few studies have compared elec-
tive surgery following stent insertionwith an emergency operation
for obstructive colorectal cancer, and no study has recommended a
proper point in time for elective surgery after stent insertion. In this
study, we evaluated clinical aspects and compared the short-term
results of radical resection to identify an effective modality for
the treatment of obstructive colorectal cancer.2. Methods
Seventy-seven patients underwent surgery for obstructive colorectal cancer at a
single center from January 2000 to July 2010. All patients with obstructive, but
resectable left sided colon cancer, and we excluded patients with a bowel perfora-
tion, massive gastrointestinal hemorrhage, right colon cancer, and patients who had
received only palliative colostomy. Forty-nine patients that underwent elective
surgery after stent insertion (stent group; SG) and 28 patients that underwent an
emergency operation for obstructive colorectal cancer (emergency group; EG) were
retrospectively reviewed. Six patients with stent obstruction or migration under-
went an emergency operation, but nonetheless, these patients were treated as
members of the stent group according to the requirements of intent-to-treatd. All rights reserved.
Table 1
Demographics of patients in the stent group (SG) and the emergency group (EG).
SG (n ¼ 49) EG (n ¼ 28) p Value
Sex (n, %) M 31 (63.3) 21 (75.0) 0.290
F 18 (36.7) 7 (25.0)
Age (year, range)a 63.6
(43w85)
56.6
(22w78)
0.024
BMI (kg/m2, range)a 22.4
(16.0w31.6)
22.6
(18.8w27.3)
0.812
ASA before surgery (n, %) I 6 (12.2) 0 0.015
II 37 (75.5) 18 (64.3)
III 6 (12.2) 10 (35.7)
CEA  SD 21.7  60.6 32.5  107.1 0.621
Underlying disease (n, %) 30 (61.2) 12 (42.9) 0.119
Stent-associated
complication
Obstruction 5 e
Migration 1 e
Tumor location (n, %) Colon 34 (69.4) 21 (75.0) 0.600
Rectum 15 (30.6) 7 (25.0)
Surgery technique (n, %) Open 36 (73.5) 28 (100) 0.003
Laparoscopic 13 (26.5) 0
Operation type TC 2 12 < 0.001
LHC 10 0
HP 6 16
AR 20 0
LAR 11 0
Stoma construction (n, %) 6 (12.2) 16 (57.1) < 0.001
TNM stage I 2 0 0.687
II 14 10
III 19 10
IV 14 8
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ORIGINAL RESEARCHanalysis. The following parameters were analyzed: sex, age, body mass index (BMI),
American Society of Anesthesiologists (ASA) scores, preoperative carcinoembryonic
antigen (CEA), underlying disease, tumor location, type of operation, operation time,
cancer stage, number of harvested lymph nodes, postoperative complications,
postoperative hospital stay, and mortality within one month of surgery. We deﬁned
postoperative ileus as an ileus pattern by abdominal radiography in patients who
had fasted more than one week after surgery.
The majority of the patients in the emergency group underwent an emergency
operation before 2004, because at that time, stent insertion for obstructive colo-
rectal cancer had not been generalized in our hospital. Subsequently, we adopted
elective surgery after stent insertion as a “bridge to surgery”, if the patient did not
have an economical problem and the medical team for stent insertionwas available.
Randomization was not an option, because it was not possible to assign a patient to
SG if an emergency surgery is required under emergent circumstances.
Stent implantation was performed when patients showed obstructive symp-
toms, such as, radiologic evidence of abdominal distension with colonic dilatation.
The stent used were self-expanding Nitinol stents (Taewoong Medical Co., Seoul)
4 cm longer than the lesion. Stents were inserted using a double-channel endoscope
(GIF-2T 240, Olympus Optical Co. Ltd., Tokyo) or a colonoscope (CF Q240L, Olympus
Optical Co. Ltd., Tokyo) under ﬂuoroscopy using the through-the-scope method. A
0.035-inch guide wire (Zebra, Microvasive, USA) was introduced through the ste-
nosis and beyond the obstruction. After removing the guide wire, water-soluble
contrast was injected via a catheter to assess the length of the lesion, and the
stent delivery catheter was introduced via the working channel of the colonoscope.
The guide wire was then re-inserted, and a stent was placed using the delivery
system. We removed the outer sheath, and then the stent was ﬁxed to the lesion by
stent expansion.
Statistical analysis was performed using SPSS ver. 13.0 (SPSS; Chicago, IL) with
univariate analysis. Categorical and ordinal variables were cross-tabulated and
analyzed using Pearson’s chi-square test and Fisher’s exact test. Continuous vari-
ables were compared using the Student’s t-test. P values of less than 0.05 were
considered signiﬁcant.SG; stent group, EG; emergency group, SD; standard deviation, BMI; body mass
index, ASA; American Society of Anesthesiologist, CEA; carcinoembryonic Antigen,
TC; total colectomy, LHC; left hemicolectomy, HP; Hartmann’s procedure, AR;
anterior resection, LAR; low anterior resection.
a Mean.
Table 2
Postoperative outcomes in the stent group (SG) and the emergency group (EG).
SG (n ¼ 49) EG (n ¼ 28) p Value
Operation time (min, range)a 263.3 (90w600) 235.4 (90w400) 0.308
Harvested lymph nodes (range)a 26.2 (4w70) 37.7 (9w104) 0.048
Gas passage (day, range)a 3.1 (1w7) 2.4 (1w5) 0.054
Diet (day, range)a 4.8 (2w8) 6.2 (3w12) 0.049
Postoperative hospital stay
(day, range)a
12.1 (6w34) 15.1 (7w31) 0.109
Hospital stay (day, range)a 24.4 (9w59) 21.7 (9w59) 0.420
Hartmann reversal (n, %) 2 (33.3) 3 (18.8) 0.467
Postoperative complication
(n, %)
8 (16.3) 7 (25.0) 0.355
Anastomotic leakb 3 0 0.297
Postoperative ileus 0 4 0.015
Atelectasis 1 1 0.685
Wound abscess 1 0 0.447
Intra-abdominal abscess 1 0 0.447
Voiding difﬁculty 1 0 0.447
Pseudomembranous colitis 1 0 0.4473. Results
Male patients was 63.3% (n ¼ 31) in SG, and 75% (n ¼ 21) in EG,
and mean ages in SG and ED were 63.6 and 56.6 years, respectively
(p ¼ 0.024). Patients with associated disease were 30(61.2%) in SG,
and 12(42.9%) in EG. BMI, CEA level, tumor location, and tumor
stage, were similar in the two groups. Colorectal obstruction
occurred in two patients in SG. A greater proportion of patients had
a higher ASA score of III in EG (SG: n ¼ 6, EG: n ¼ 10, p ¼ 0.015).
Laparoscopic surgery was performed only in SG. The operation
methods of SG were; total colectomy (n ¼ 2), left hemicolectomy
(n ¼ 10), Hartmann’s operation (n ¼ 6), anterior resection (n ¼ 20),
and low anterior resection (n ¼ 11). In EG, the number of total
colectomy and Hartmann’s operation were 12 and 16, respectively.
One-staged operation rate were 87.8% (n¼ 43) in SG, 42.9% (n¼ 12)
in EG (p < 0.001) (Table 1).
The mean number of harvested lymph nodes were 26.2 in SG
and 37.7 in EG (p¼ 0.048), but both groups were more than enough
according to the guidelines for an adequate cancer operation. No
signiﬁcant intergroup difference was found for operation time, gas
passage, hospital stay, Hartman’s procedure, or overall complica-
tion rate. Anastomosis site leakage were 3 cases in SG (p ¼ 0.297),
and postoperative ileus were 4 cases in EG (p ¼ 0.015). No 30-day
mortality occurred in SG. However, one mortality occurred in EG
due to acute respiratory distress syndrome; his preoperative ASA
score was III (Table 2).
The anastomosis leakage was in one case among patients that
underwent elective surgery with less than a 10-day interval after
stent insertion, but no leakage among those with  a 10-day in-
terval (p ¼ 0.037) (Table 3).
Themean followupwas38.7months, and theoverall survival rate
at three years were 68.8% in SG and 51.3% in EG (p ¼ 0.430) (Fig. 1).Ureter injury 0 1 0.183
Intra-abdominal bleeding 0 1 0.183
Mortality 0 1 0.183
SG; stent group, EG; emergency group.
a Mean.
b Among 43 patients.4. Discussion
There is still controversy in the treatment of obstructed colon
cancer. Primary excision of the tumor with formation of an endcolostomy (Hartmann’s procedure) has been conducted commonly.
Some have represented subtotal or total colectomy with primary
anastomosis is a safe procedure.11
However, some factors like thinned out bowel and debilitated
patients make it difﬁcult to conduct primary anastomosis. Patients
with obstructive colon cancer have a morbidity of up to 50% and a
mortality of 15w20% due to dehydration, electrolyte imbalance,
concurrent diseases, infection, and sepsis.2,4,12e15 Dohmoto et al.
ﬁrst conducted stent insertion in patients with obstructive colo-
rectal cancer for palliative purposes.16 Since the late 1990s, stent
Table 3
Anastomotic leakage according to time between stent insertion and surgery in the
stent group.
Interval following stent
insertion (day)
Leak (%) No leak (%) p Value
1w6 1 (20) 4 (80) 0.224
7 2 (5.3) 36 (94.7)
1w9 3 (20) 12 (80) 0.037
10 0 28 (100)
SG; stent group, EG; emergency group.
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colorectal obstruction, because it offers the advantages of cost
saving, enabling curative resection via a one-stage operation, and
improving quality of life.17
The success rate of endoscopic stenting has been reported to be
75 w 100%.10,18 Its main complications are intestinal perforation,
stent displacement, stent stenosis, and other complications, such
as, minor bleeding, tenesmus, and constipation.19e22 Furthermore,
intestinal perforation has been reported to occur in up to 5% and to
be the most severe complication of endoscopic stenting.17,23
No stent insertion is conducted for rectal cancer located within
5 cm superiorly to the anal verge, because the stent itself may
stimulate the anus and levator ani. In the present study, no patient
with obstructive colorectal cancer located 5 cm above anal verge
complained of tenesmus after stent insertion.
It is always difﬁcult for surgeons to determine whether emer-
gency surgery or stent insertion should be conducted in patients
with obstructive colorectal cancer. Few prospective randomized
studies have addressed this issue, and subject numbers have been
limited (Table 4). Although no statistical signiﬁcance was found in
some of studies, enterostomy closure rate, complication rate,
mortality rate, hospital stay, and ICU stay have generally been
shown to be lower in stent insertion groups than in emergency
surgery groups. Martinez et al. reported that one-stage curative
resection was successful in 41.4% of all patients and in 84.6% of
patients that underwent preoperative stent insertion, and
concluded surgery after stent insertion was advantageous.10 In
addition, they also reported that enterostomy closure occurred in
15% of SG and in 59% of EG. In the present study, curative resection
was successful via one-stage operation in 42.9% of EG and in 87.8%
of SG, which concurs with the results of the previous studies. In
addition, Hartmann’s operation was performed in 12.2% of SG, and
in 57.1% of EG. Thus, the proportion that underwent enterostomy0 12 24 36 48 60
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Fig. 1. Overall survival of stent group and emergency operation group. SG; stent group,
EG; emergency group, OS; overall survival.closure, which is not preferred by patients, was lower among pa-
tients that underwent surgery after stent insertion (p < 0.001).
Hartmann’s reversal was performed in 33.3% of SG (2/6), and in
18.8% of EG.
Ostomy-related complications account for much of the deteri-
oration in quality of life. These complications have an incidence rate
of approximately 34%, and include skin irritation with pain caused
by inappropriate ostomy location, partial necrosis, prolapse, and
stoma stenosis.10 It has been reported that enterostomy closure is
achieved in approximately 60% of patients who underwent ostoma
procedure.2 In this study, patients who underwent Hartmann’s
operation in EG were mainly old patients with concurrent diseases,
and the rate of enterostomy closure was low as the patients refused
secondary surgery. Total colectomy or Hartmann’s operation was
mainly conducted in EG. This was because primary anastomosis
was avoided due to a poor systemic status, severe bowel edema, or
ischemia of the colorectal wall, and because no appropriate intes-
tinal preparation device was available in the operation room.
Important late complications of stent insertion include stent
obstruction and stenosis due to tumor proliferation or stent
displacement. These complications are caused by inappropriate
stent selection, wrong positioning, and bowel movement, and can
be reduced by using appropriate sized-stents and by exercising
skill.19,24,25 In the present study, ﬁve (10.2%) in the stent group
experienced stent obstruction and one (2%) experienced stent
displacement.
Preoperative stent insertion improves systemic status and en-
ables intestinal cleaning by resolving intestinal obstruction, and
thereby, improves hygienic status of the intestine, and reduces the
risk of postoperative infection in patients with obstructive colo-
rectal cancer. In addition, it enables preoperative examination of
concurrent tumors of the proximal colorectum, resolves problems,
such as, dehydration, electrolyte imbalance, ameliorates ischemic
injury caused by a dilated intestine, and enables surgery to be
conducted under the best conditions by allowing concurrent dis-
eases to be assessed and treated before surgery.18,26 In the present
study, when systemic statuses were assessed before surgery, ASA
score was found to be lower in SG than in EG (p ¼ 0.015). In addi-
tion, open surgery was only performed in EG because it was difﬁ-
cult to secure the space required for laparoscopic surgery due to
severe bowel dilatation. On the other hand, laparoscopic surgery
was conducted on patients in SG because preoperative bowel
cleaning and recovery of dilated intestine were achieved by stent
insertion (p¼ 0.003). Laparoscopic surgery was known as a manner
reminiscent of the faster recovery, less pain, and shorter
hospitalization.27,28
Preoperative stent insertion has been reported to have the ad-
vantages of reducing postoperative complications and shortening
total hospital stay and ICU stay.10,29 In the present study, no inter-
group difference was observed in terms of time to gas passage after
surgery, and the times to diet after surgery were 4.8 days in SG and
6.2 days in EG, which was a signiﬁcant difference (p ¼ 0.049).
Despite the aforementioned results, delay to diet in EG was prob-
ably due to a poorer systemic status in EG, and that ICU manage-
ment was required to improve vital signs in this group.
Emergency surgery on patients with obstructive colorectal
cancer has been reported to have a complication rate of 32w 62%
and a mortality of 12.5w 26%.2,3,9,23,30e36 In the present study, the
complication rate in elective surgery following stent insertion was
16.3% as compared with 25.0% in EG, which was statistically
insigniﬁcant (p ¼ 0.355). Saida et al. reported a rate of anastomotic
leakage of 3% in patients that underwent surgery after stent
insertion and 11% in patients that underwent emergency surgery.29
In the present study, the rate of anastomotic leakage was 7% in SG,
which was slightly higher than in the previous study, but it
Table 4
Comparison of studies on colonic stenting versus emergency surgery for malignant colon obstruction.
Study Design Group No Age Sex (M/F) Tumor Location Stoma Cx ICU stay Hospital stay RO Mortality
Year D-colon S-colon Rectum
Martinez et al10 RT SG 43 71 26/17 11 18 14 4a(12%) 17(40%) 0.3a 14.2a 0a 4(9%)
2002 EG 29 74.6 15/14 10 15 4 17(54%) 18(62%) 2.9 18.5 5(17%) 7(24%)
Ng et al23 CMS SG 20 74 17/3 3 7 10 1a(5%) 6(22%) 0a 9a 1(5%) 1(5%)
2006 EG 40 73.5 29/11 12 28 0 11(28%) 22(55%) 0.5 12 4(10%) 5(13%)
Ho et al36 PRT SG 20 68 13/7 5 10 5 2(10%) 7(35%) 2 14 e 0
2012 EG 19 65 9/10 8 8 3 6(32%) 11(58%) 3 13 e 3(16%)
Hooft et al35 PRT SG 47 70.4 24/23 e e e 27(57%) 25(53%) e e e 9(19%)
2011 EG 51 71.4 27/24 e e e 34(67%) 23(45%) e e e 9(18%)
Angenete et al30 RT SG 112 73 57/55 92 20a 39(35%) 25(24%) e e e e
2011 EG 60 73 28/32 57 3 60(53%) 20(33%) e e e e
Law et al31 RT SG 30 75 20/10 2 10 18a 4a(13%) 7(23%) e 4a e 4(13%)
2003 EG 31 70 20/11 9 16 6 15(48%) 10(32%) e 8 e 8(26%)
Carne et al32 RT SG 25 66 13/12 4 12 9 2a(8%) 6(24%) e 4a e 1(4%)
2004 EG 19 68 12/7 2 6 11 12(63%) 9(36%) e 10.4 e 3(16%)
Dastur et al33 RT SG 19 75 10/9 2 12 5 5(26%) e e 4 e 1(9%)
2008 EG 23 68 14/9 8 14 1 12(52%) e e 16 e 3(13%)
Guo et al34 RT SG 34 77 19/15 9 19 6 7a(21%) 8(24%) e 19 e 1a(3%)
2011 EG 58 76 28/30 13 34 11 31(52%) 23(40%) e 14 e 11(19%)
SG; stent group, EG; emergency group, Cx; complication, RO; reoperation, RT; retrospective trial, CMP; case-matched study, RPT; randomized prospective trial.
a p Value is lower than 0.05 for SG versus EG.
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tients were treated conservatively, for example, by fasting and
administering antibiotics without re-laparotomy. Postoperative
ileus was examined in patients that fasted for one or more weeks
after surgery, and was found to be signiﬁcantly higher in EG
(p ¼ 0.015). Hooft et al. and Ng et al. also reported that the rate of
postoperative ileus was higher in EG, albeit without statistical
signiﬁcance.23,35 In the present study, no death occurred among
patients that underwent elective surgery. On the other hand, one
patient (3.6%) succumbed to acute respiratory distress syndrome
within 30 days of surgery in EG.
This study has limitations that warrant mention. First, statistical
analyses of differences between the two groups were limited by
small patient numbers. Second, the study is limited by its retro-
spective nature, and the treatment selectionwas determined based
on considerations of patient status and by physician’s judgment.
However, because ethically, it is not possible to assign a patient to
SG if an emergency surgery is required under emergent circum-
stances, randomization was not an option.
Usually, surgery is performed 1w 2 weeks after stent insertion,
and it has been reported that this time is appropriate for avoiding
of stent-induced peritumor inﬂammation and adhesion.37 Hooft
et al. reported an interval of 5 w 14 days in a multicenter study,
and found that the risk of anastomotic leakage increased due to
insufﬁcient intestinal decompression and recovery of systemic
status when time from stent insertion to surgery was short.35 Ho
et al. reported a mean time from stent insertion to surgery of 10
days, and found that a time of 9 w 14 days was appropriate, and
that the risk of surgery increased if this time was greater than 2
weeks.36 Postoperative anastomotic leakage causes complications,
such as, intra-abdominal infection and abscess formation, and
even death in severe cases. In the present study, times of surgery
were divided using cut offs of 1 week and 10 days after stent
insertion, and it was found that postoperative anastomotic leakage
occurred less frequently in patients that underwent surgery 10
days or more after stent insertion than in the patients who un-
derwent surgery within 10 days of stent insertion (p ¼ 0.037),
which suggests that it is safer if curative surgery is conducted 10
days or more after stent insertion. However, considering the small
number of the patients recruited and a lack of consideration of
other factors that affect anastomotic leakage, further study is
required.In conclusion, in obstructive colorectal cancer, elective surgery
after stent insertion seems to be safe, and may have enabled
laparoscopic surgery to be conducted. In addition, as compared
with emergency surgery, one-stage operation that does not require
colostomy can be applied after stent insertion. And our ﬁndings
suggest that is safer to conduct curative surgery 10 days or more
after stent insertion to reduce risk of anastomotic leakage. A further
large-scale, randomized, prospective study is required to determine
the appropriate time to conduct the surgery after stent placement
and to analyze the oncological safety of elective surgery after stent
insertion in obstructive colorectal cancer.
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